Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy

E-ISSN： 1875-5992|10|4|312-323

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.4, 2010-05, pp. : 312-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Old and new drugs in systemic therapy of pancreatic cancer

By Pasetto L.M. Jirillo A. Stefani M. Monfardini S.

Critical Reviews in Oncology/Hematology, Vol. 49, Iss. 2, 2004-02 ,pp. : 135-151

Elsevier

Access to resources Recommend Favorite

Progress in systemic therapy for breast cancer: an overview and perspectives

By Piccart M.J. Cardoso F.

EJC Supplements, Vol. 1, Iss. 2, 2003-09 ,pp. : 56-69

Elsevier

Access to resources Recommend Favorite

Interferon Therapy in Lung Cancer: Current Perspectives

Current Cancer Therapy Reviews, Vol. 12, Iss. 4, 2017-05 ,pp. : 237-245

Bentham Science Publishers

Access to resources Recommend Favorite

Bacteriochlorophyll a and Its Derivatives: Chemistry and Perspectives for Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 683-697

Bentham Science Publishers

Access to resources Recommend Favorite

Novel gene therapy approaches to pancreatic cancer

By Katz Matthew Bouvet Michael

International Journal of Gastrointestinal Cancer, Vol. 33, Iss. 1, 2003-02 ,pp. : 89-97

Humana Press, Inc

Access to resources Recommend Favorite